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1. INTRODUCTION 
Germ cells (GC) are unique in their capacity to divide meiotically and to halve 
their genetic material, generating haploid gametes, oocytes in the female and 
spermatozoa in the male, that transfer the genetic information from one generation to 
the next. Due to ethical issues restricting access to human material for research 
purposes, studies documenting the fate of human GC are sparse and much of what is 
known about gamete formation has been obtained from the mouse. However, the 
characteristic cellular events and chronology of the key steps of gametogenesis are 
similar in mice and humans. 
The first GC population established during development, primordial GC (PGC) 
are segregated from the somatic cell lineage (epiblast) at early gastrulation, around 
embryonic day (ED) 6.25 in the mouse. PGC proliferate while migrating along the 
hindgut endoderm to reach the embryonic gonads during the late embryonic period 
(i.e., ED10.5-ED11.0) (reviewed in McLaren & Lawson, 2005). Once in the gonad and 
now known as gonocytes (Clermont & Perey, 1957), GC follow a sexually dimorphic 
pathway dictated by cues from the somatic cells (Fig. 1). In the fetal ovary, female 
gonocytes initiate prophase I of meiosis at about ED13.5. As primary oocytes, they 
pass through the leptotene, zygotene and pachytene stages before arresting after birth 
in diplotene, surrounded by a single layer of somatic, follicle cells. Upon completion of 
puberty, several primary oocytes achieve meiosis I and then divide, yielding haploid 
secondary oocytes at each menstrual cycle (Fig. 1). Progression through meiosis in 
oocytes pauses again in metaphase II, shortly before ovulation, to complete the second 
meiotic division after fertilization in the oviduct. In the fetal testis, male gonocytes, 
surrounded by somatic cells of the testis cords, undergo a mitotic arrest in G0/G1 
(Fig. 1). After birth, they resume proliferation and undergo a transition to 
spermatogonia. Meiosis in primary spermatocytes begins during the prepubertal 
period, by the end of the first post-natal week (PNW). The two meiotic divisions 
proceed without interruption, leading to the formation of haploid secondary 
spermatocytes, then of round spermatids. The latter undergo morphological changes 
to finally become spermatozoa (Fig. 1). Spermatogenesis, the process yielding 
spermatozoa from spermatogonia, is completed for the first time at PNW5 and 
continues throughout adulthood. It takes place in the seminiferous epithelium of the 
testis, under the control of a somatic, supporting, cell-type called the Sertoli cell 
(reviewed in Bowles & Koopman, 2007; Kocer, Reichmann, Best, & Adams, 2009; 
Griswold, 2016). 
Spermatogenesis is critically dependent upon vitamin A (vitA), acting through its 
metabolite, all-trans retinoic acid (ATRA). This has been clear since the pioneering 
study by Wolbach & Howe (1925) showing that spermatogenesis fails in rats fed a vitA-
deficient diet, and the subsequent demonstration that it can be successfully restored 
upon systemic administration of ATRA. Then, several genetic and pharmacological 
studies have highlighted the importance of ATRA in regulating meiosis. 
The canonical pathway for ATRA signaling has been elucidated over the years, 
mainly though gene targeting studies in the mouse (Fig. 2). Conversion of vitA to ATRA 
requires two sequential oxidative steps. The first one is catalyzed by either cytosolic 
alcohol dehydrogenases or microsomal retinol dehydrogenases (RDH) to generate 
retinaldehyde (RAL). The second step, generating ATRA, is catalyzed by RAL 
dehydrogenases (RALDH1, RALDH2, and RALDH3, encoded by the Aldh1a1, 
Aldh1a2 and Aldh1a3 genes, respectively). In cells, ATRA binds to and activates 
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nuclear receptors (RARA, RARB and RARG), which are ligand-dependent 
transcriptional regulators. They usually function in the form of heterodimers with 
rexinoid receptors (RXRA, RXRB and RXRG) to control expression of ATRA-target 
genes through binding to retinoic acid response elements (RARE) located in genomic 
regulatory regions. Aside from synthesis, degradation of ATRA is also an important 
mechanism that protects cells from inadequate ATRA stimulation. It is catalyzed by 
three cytochrome P450 hydroxylases (CYP26A1, CYP26B1 and CYP26C1), which 
hydroxylate ATRA into water-soluble products that are less active and readily 
excretable (reviewed in Duester, 2008; Samarut & Rochette-Egly, 2012). 
In this review, we discuss our current understanding on how ATRA regulates GC 
differentiation and entry into meiosis. We also provide complementary information and 
some novel details as to the sources and the functions of ATRA in these processes. 
2. ATRA SIGNALING AND GONOCYTES IN THE FETAL GONADS 
The timing of meiosis entry in mammals is strikingly different in males and 
females (Fig. 1). It has been hypothesized that the decision of female GC to enter 
meiosis is an intrinsic property (i.e., a GC autonomous event, for instance timed by cell 
divisions), with no reference to somatic cues: they spontaneously enter meiosis at 
ED13.5 unless prevented from doing so by a putative meiosis preventing substance 
(MPS). The fact that disaggregated ED11.5 male GC enter meiosis when transferred 
to lung cell aggregates favors the existence of a MPS synthesized by somatic cells of 
the fetal testis and acting on GC at a short distance. An alternative hypothesis 
proposes that GC enter meiosis under the influence of a somatic, diffusible, meiosis 
inducing substance (MIS), whose existence in the fetal mouse ovary, but not testis, 
was deduced from co-culture experiments. Such a MIS has to be also present in non-
gonadal sites, because GC that fail to reach the gonad but instead migrate to ectopic 
sites as, for instance, the mesonephros, enter meiosis irrespective of their genetic sex. 
It is worth noting here that the MPS hypothesis can also account for the fact that male 
gonocytes enter meiosis in non-gonadal sites, where they escape the inhibitory 
influence of MPS. Whether meiosis entry requires a female MIS only, a male MPS only, 
or both a MIS and a MPS is still a matter of debate, even though the latter option 
represents the prevailing model (reviewed in Bowles & Koopman, 2007; Kocer, 
Reichmann, Best, & Adams, 2009). 
2.1. CYP26B1 acts as a MPS for male gonocytes 
The possible role for endogenous ATRA in mouse GC differentiation was initially 
raised by the sexually dimorphic expression of Cyp26b1, which is expressed in the 
embryonic gonads of both sexes at ED11.5, but becomes male-specific by ED12.5 with 
strong expression in the somatic cells of the testis (Bowles et al., 2006; Fig. 3). Then, 
pharmacological studies have shown that exposure of embryonic testes in organ 
culture to exogenous ATRA or to the CYP inhibitor ketoconazole induces (i) aberrant 
expression of meiotic markers such as Stra8 (encoding a meiotic gatekeeper, see 
below), Dmc1 (encoding a meiotic recombinase) and Sycp3 (encoding a synaptonemal 
complex protein) and (ii) the appearance of chromosomal aggregates resembling 
cytological figures observed during meiotic prophase I (Bowles et al., 2006). As a 
simultaneous exposure to ketoconazole and to the pan-RAR inverse agonist BMS-
204493 prevents these meiotic events, this suggests that ketoconazole, although not 
CYP26B1-specific, induces untimely meiosis in the testis through an inappropriate 
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induction of the RAR signaling pathway (Koubova et al., 2006). The role of CYP26B1 
in preventing meiosis entry in the fetal testis was confirmed in vivo by functional 
analysis of Cyp26b1–/– mutants: meiotic GC expressing Sycp3 are observed at ED13.5, 
at the time when GC in ovaries enter meiosis, in sharp contrast to the normal situation 
where meiosis initiates in the testis at the earliest by post-natal day (PND) 7 (MacLean, 
Li, Metzger, Chambon, & Petkovich, 2007). Altogether, these findings are compatible 
with the possibility that CYP26B1 stands for or synthesizes the MPS. 
2.2. CYP26B1 prevents proliferation as well as death of male gonocytes 
In the mouse testis Cyp26b1 is also expressed during the ED12.5-ED14.5 period, 
when male gonocytes undergo mitotic arrest in G0/G1 (quiescence) (Western, Miles, 
van den Bergen, Burton, & Sinclair, 2008; Fig. 3). Pharmacological inhibition of CYP26 
activity in organ culture of testes prevents the mitotic arrest of male GC and induces 
their death by apoptosis. These data suggest that impairing CYP26 action in the male 
fetal gonad, not only prevents gonocytes from entering meiosis, but also allows the 
establishment of their quiescent state and survival (Trautman et al., 2008). Similar 
conclusions were reached by Li, MacLean, Cameron, Clagett-Dame, & Petkovich 
(2009) who generated a Sertoli cell-specific knockout of Cyp26b1 starting at ED15 
(Cyp26b1SC-/SC- mutants). In these mutants, some gonocytes exited from the G0 stage 
to re-enter the mitotic cycle, expressed SYCP3, indicating that they underwent 
inappropriate initiation of meiotic prophase I, and were subsequently lost from the 
seminiferous cords before birth. It is however noteworthy that ablation of Cyp26b1 in 
Sertoli cells most probably accounts only very partially for the functions of the enzyme 
in the developing testis, because the large majority of Cyp26b1 transcripts is detected 
outside the fetal seminiferous cords, in the somatic cells located in the interstitial 
spaces (Abu-Abed et al., 2002; Fig. 3) and is clearly confined to the peritubular myoid 
cells from birth (PN0) onwards (Vernet et al., 2006a; our unpublished results). It is 
therefore not surprising that another study showed that ablation of CYP26B1 activity 
in Sertoli cells from ED15 onwards has in fact little impact on adult spermatogenesis 
(Hogarth et al., 2015b). The combined results of these pharmacological and genetic 
experiments altogether suggest that increased ATRA levels induce aberrant entry of 
into meiosis, inappropriate cell proliferation and massive cell death amongst male 
gonocytes. 
Thus, if exposure to ATRA is deleterious to male gonocytes, what might be the 
physiological significance of the strong and steady expression of RALDH1 in the 
immature Sertoli cells forming the cords of the fetal testis (Bowles et al., 2009; Fig. 3)? 
In an attempt to answer this question, we analyzed the outcome of ablating all RALDH 
genes in Sertoli cells, as early as ED15 (Aldh1a1-3Ser−/− mutants) (Raverdeau et al., 
2012). At ED18.5, about 24 hours before birth, all gonocytes in testes of wild-type (WT) 
and Aldh1a1-3Ser−/− mutants are mitotically arrested (Fig. 4). They express the receptor 
tyrosine kinase KIT, a general marker of gonocytes (Fig. 4), but never GFRA1 nor 
ZBTB16, both of which are markers of undifferentiated spermatogonia. Then, WT and 
Aldh1a1-3Ser−/− mutant gonocytes express GFRA1 and ZBTB16 at PND1 (Fig. 4), 
resume proliferation by PND2 and migrate to the basement membrane until PND6 to 
adopt a spermatogonial phenotype (Kluin, Kramer, & de Rooij, 1982; Nagano et al., 
2000). As RALDH1 in Sertoli cells is the main source of ATRA for male fetal GC, this 
finding indicates that ATRA is not physiologically required to control the mitotic arrest 
of gonocytes, their migration from the center of the testicular cords to the basement 
membrane and their transition to spermatogonia. The reason for the robust expression 
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of RALDH1 in Sertoli cells before birth is therefore still elusive. It is however noteworthy 
that RALDH1 exhibits a broad substrate speciﬁcity and can function as a detoxifying 
enzyme for xenobiotics (Alnouti & Klaassen, 2008). Whether this is indeed the case 
during testis development remains to be tested. 
2.3. ATRA is required for the production of “differentiating” spermatogonia 
from male gonocytes 
In the mouse, the transition from gonocytes to spermatogonia occurs during the 
perinatal period, prior to the onset of prepuberty. Male gonocytes are the precursors of 
the stem spermatogonia and can also directly differentiate, without passing by the stem 
cell stage, into differentiating spermatogonia that support the first wave of 
spermatogenesis (Yoshida et al., 2006). Moreover, it has been suggested that 
gonocytes that fail to differentiate into spermatogonia may provide the source for 
formation of carcinoma in situ, the precursor lesion of most testicular germ cell cancer 
in humans (Soone et al., 2009). For these reasons, the transition from gonocytes to 
spermatogonia is an important step of the differentiation pathway leading to male 
gametes. 
We found that GC from Aldh1a1-3Ser−/− mutant definitively loose KIT at PND3 as 
they do not reinitiate the transcription of the Kit gene, as it is normally the case at PND3 
(Yoshida et al., 2006; Fig. 4). Moreover, germ cells from Aldh1a1-3Ser−/− never express 
STRA8 in contrast to WT gonocytes (Fig. 4). This latter observation is in keeping with 
the previous finding that expression of Stra8 is delayed in spermatogonia of neonatal 
Aldh1a1–/– mutants (Vernet et al., 2006b). The data presented here thus indicate that 
ATRA synthesis by Sertoli cells is necessary after birth for the production, from 
gonocytes, of the spermatogonia which initiate the first wave of spermatogenesis 
(Yoshida et al., 2006). 
2.4. ATRA possibly acts as a MIS for female gonocytes 
It is now admitted that ATRA acts as a MIS (Griswold, Hogarth, Bowles, & 
Koopman, 2012). Nonetheless, the tissue from which originates the ATRA that induces 
meiosis in mouse fetal ovaries was disputed for several years. Studies of mice carrying 
an ATRA-dependent reporter transgene (RARE-hsp90-LacZ; Rossant, Zirngibl, Cado, 
Shago, & Giguère, 1991), revealed that the responsiveness to ATRA is weak in the 
gonads, but robust in the mesonephroi of both sexes (Bowles et al., 2006; Koubova et 
al., 2006). As, both Aldh1a2 mRNA (Bowles et al., 2006) and RALDH2 protein (Fig. 3) 
are detected in mesonephroi of both sexes from ED11.5 to ED13.5, but not in the 
gonad itself, it was concluded that the source of ATRA detected in the ovary at the time 
of meiotic initiation is the adjacent mesonephros. Together these findings generated a 
model for the sex-specific timing of meiosis entry, according to which ATRA 
synthesized by the mesonephros serves as an extrinsic MIS acting in the adjacent 
gonad, unless degraded by CYP26B1, the MPS. 
It is however noteworthy that the coelomic epithelium, which covers the 
embryonic gonad, also strongly expresses both Aldh1a2 transcripts (Niederreither, 
McCaffery, Dräger, Chambon, & Dollé, 1997) and RALDH2 protein (Fig. 3). Thus, it 
can also function as a source of ATRA, closer to GC than the mesonephros. On the 
other hand, Kumar et al. (2011) have challenged the view that ATRA is required for 
entry of ovarian gonocytes in meiosis. Actually, by analyzing mice carrying null 
mutations for RALDH2, singly or in combination with null mutations for RALDH3 
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(Aldh1a2–/– and Aldh1a2–/–;Aldh1a3–/– mutants), they show that the RARE-hsp90-LacZ 
activity typically observed throughout the normal mesonephros and the gonads is 
totally eliminated, as expected. Yet, both mutant and WT ovaries exhibit similar 
expressions of meiotic effectors such as Stra8, Sycp3 and phosphorylated H2AX 
histone, which marks DNA double-strand breaks occurring during meiotic 
recombination. The authors conclude that meiosis occurs normally, the lack of 
detectable ATRA in the vicinity of the ovaries. Nevertheless, these observations left 
open the possibility that RALDH1 might be also involved. This hypothesis has been 
neglected for a long time likely because (i) Aldh1a1–/– mice are viable and fertile (Fan 
et al., 2003; Matt et al., 2005); (ii) RALDH1 has the lowest affinity for RAL, being about 
15-fold less efficient than RALDH2 at producing ATRA (Gagnon, Duester, & Bhat, 
2002); and (iii) RALDH1 has been proposed to be marginally involved in ATRA 
synthesis in vivo (Niederreither, Vermot, Fraulob, Chambon, & Dollé, 2002). The fact 
remains that both Aldh1a1 mRNA and RALDH1 protein are detected in somatic cells 
of the developing gonads which are in direct contact with gonocytes (Fig. 3), and 
meiosis is indeed delayed in the Aldh1a1–/– ovary, as judged by the expression of 
marker genes (Bowles et al., 2016). Thus, in spite of its low capability of ATRA 
synthesis, RALDH1 activity appears to participate in meiotic initiation in female GC. By 
remaining expressed in Aldh1a2–/–;Aldh1a3–/– mutants, it may compensate for the loss 
of the two other ATRA-synthesizing enzymes. The observation that cultured GC 
upregulate meiotic genes in response to 1 nM ATRA supports the view that ATRA at 
low concentrations is able to favor meiosis (Bowles et al., 2010; Tedesco, Desimio, 
Klinger, De Felici, & Farini, 2013). 
2.5. Stra8 as the meiotic gatekeeper 
A wealth of data support the model whereby ATRA acts as the MIS by inducing 
the expression of STRA8, a 45 kD vertebrate-specific protein (Oulad-Abdelghani et al., 
1996). STRA8 actually functions as a “meiotic gatekeeper” by controlling the switch 
between GC division by mitosis and meiosis, as evidenced by gene knockout studies 
in the mouse (Baltus et al., 2006; Anderson et al., 2008; Mark et al., 2008). The Stra8 
promoter contains a RARE which can bind to RAR/RXR heterodimers, making this 
gene a possible direct target of ATRA (Kumar et al., 2011; Raverdeau et al., 2012). 
Moreover, the normal expression of Stra8 in female gonocytes is inhibited in fetal 
ovaries cultured in the presence of the pan-RAR inverse agonist BMS-204493 
(Koubova et al., 2006), and ATRA at supra-physiological levels can stimulate 
expression of Stra8 when added to the medium of cultured embryonic testes from mice 
(Baltus et al., 2006; Bowles et al., 2006; Koubova et al., 2006), humans (Le Bouffant 
et al., 2010) and amphibians (Wallacides, Chesnel, Chardard, Flament, & Dumond, 
2009; Piprek et al., 2013), suggesting that the requirement of ATRA for meiosis entry 
could be a conserved mechanism in tetrapods. 
These data must, however, be interpreted with caution for three reasons. First, it 
has been recurrently emphasized that developmental alterations generated by added 
ATRA do not necessarily reflect cellular processes operating in real life (Horton & 
Maden, 1995; Mark, Ghyselinck, & Chambon, 2006). Second, neither expression Stra8 
nor up-regulation of meiotic markers is synonymous of entry into meiosis. For instance, 
expression of STRA8 and proteins associated with key meiotic processes occurs in 
spermatogonia, well before the appearance of premeiotic spermatocytes (Mark, 
Teletin, Vernet, & Ghyselinck, 2015; Evans, Hogarth, Mitchell, & Griswold, 2014). 
Third, silencing of Stra8 expression by the pan-RAR inverse agonist BMS-204493 
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does not necessarily reflects impairment of its induction by endogenous ATRA-
activated RAR because this synthetic retinoid stabilizes interaction between 
corepressor complexes and RAR, whether naturally bound by ATRA or not. By 
tethering corepressor-associated histone deacetylase activities, it may silence genes 
containing RARE but not necessarily activated by endogenous ATRA-bound RAR 
(Germain et al., 2009). Thus, although STRA8 is indisputably instrumental to proper 
meiosis, the control of its expression by endogenous ATRA in female GC is more 
controversial. 
2.6. An alternative viewpoint of meiosis induction in female gonocytes 
Interpretations of the data showing an involvement of ATRA in meiosis are guided 
by the prevailing idea that both a MPS and a MIS are required to explain the sex-
specific timing of meiotic initiation (reviewed in Bowles & Koopman, 2007; Kocer, 
Reichmann, Best, & Adams, 2009; Griswold, Hogarth, Bowles, & Koopman, 2012). 
This is mainly due to the pioneering finding that Cyp26b1, whose function is 
supposedly to degrade ATRA, is expressed in the male, but not in the female fetal 
gonad where meiosis initiates. Since then, Kumar et al. (2011) have proposed that 
CYP26B1 may instead metabolize a substrate that is distinct from ATRA (for instance 
another aldehyde). It must be emphasized that considering the “MPS only” hypothesis 
to interpret the current data would reconcile the apparent discrepancies existing in the 
literature. According to this scenario, inducing quiescence instead of meiosis in male 
gonocytes would require a yet unknown substance produced by CYP26B1 (the MPS). 
On the opposite, entering meiosis in female gonocytes would be an autonomous, 
intrinsic, property of GC without the requirement of any MIS, including ATRA 
synthesized by RALDH1 or another RALDH. Interestingly, several authors propose 
that ATRA in the fetal ovary is involved in GC proliferation rather than meiosis initiation 
(Koshimizu, Watanabe, & Nakatsuji, 1995; Morita & Tilly, 1999; Trautmann et al., 2008; 
Jørgensen et al., 2015). 
3. ATRA SIGNALING IS INSTRUMENTAL TO SPERMATOGONIA 
DIFFERENTIATION IN THE PREPUBERTAL AND ADULT TESTIS 
Spermatogenesis is initiated during the prepubertal period in the seminiferous 
epithelium (SE) and then proceeds throughout adulthood. In the mouse, the initial wave 
of spermatogenesis, which starts around PN2, and is completed by PN35, involves a 
subpopulation of gonocytes (Yoshida et al., 2006). The subsequent prepubertal and all 
adult waves derive only from spermatogonia. These cells have traditionally been 
classified into “undifferentiated” and “differentiating” based on their ability to self-renew 
and differentiate (de Rooij & Russell, 2000). Undifferentiated type A (Aundiff) 
spermatogonia are endowed with stem cell functions: they can (i) maintain their own 
population, thereby ensuring long term maintenance of the germline and (ii) produce 
daughter cells that differentiate into spermatozoa. Based on whole-mount analyses of 
seminiferous tubules, Aundiff spermatogonia collectively correspond to Asingle (As, 
isolated single) spermatogonia which, upon division, give rise to syncytia consisting of 
2 Apaired (Apr), 4 Aaligned-4 (Aal-4), 8 (Aal-8), 16 (Aal-16) cells and occasionally 32 cells 
interconnected by cytoplasmic bridges resulting from incomplete cytokinesis (reviewed 
in de Rooij & Russell, 2000; Fig. 5). Cell lineage tracing experiments indicate that a 
subpopulation of As spermatogonia is responsible for the stem cell function in steady 
state spermatogenesis but its Aal progeny retains the potential to revert to As and 
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reconstitute the entire spermatogenesis when the tissue is damaged or when these 
cells are transplanted into GC-depleted seminiferous tubules (Hara et al., 2014; and 
references therein; Fig. 5). Aundiff spermatogonia are evenly distributed along 
seminiferous tubules. They periodically exit from the stem cell pool and differentiate 
without a mitotic division into differentiating, type A1 spermatogonia. This step known 
as the Aaligned to A1 (Aal-A1) transition is considered as the entrance in the differentiation 
pathway ultimately yielding spermatozoa. Five mitotic divisions follow A1 formation, 
producing sequentially A2, A3, A4, intermediate (Int) and B spermatogonia and 
accompanying elongation of the syncytial chains. Types A1 to B spermatogonia 
referred to as “differentiating spermatogonia” are committed towards the pathway 
yielding spermatocytes (Fig. 5). They lose their capacity for self-renewal (Shinohara, 
Orwig, Avarbock, & Brinster, 2000) and differentiate at precise intervals along the 
seminiferous tubules, each step of differentiation being coupled with a mitotic division 
(de Rooij, 1998). 
KIT and STRA8 are restricted to differentiating spermatogonia and the onset of 
their synthesis, detected by IHC (and/or by ISH) during the progression of 
spermatogonia differentiation, is a commonly accepted hallmark of the Aal-A1 transition 
(Schrans-Stassen, van de Kant, de Rooij, & van Pelt, 1999; Ghyselinck et al., 2006). 
Other proteins that are linked with cell fate or function represent useful tools to 
characterize the state of spermatogonia differentiation in immunohistochemical assays 
(Fig. 5). 
3.1. The transition from undifferentiated to differentiating spermatogonia 
critically relies on ATRA 
The finding that ATRA is a key regulator of the Aal-A1 transition was brought about 
by vitA deficiency studies. Depriving adult rodents in vitA induces a rapid loss of meiotic 
spermatocytes and spermatids, ultimately yielding seminiferous tubules containing 
only Sertoli cells, spermatogonia and, in the case of rats, preleptotene spermatocytes. 
Based on cell kinetic properties and on the absence of Kit expression, the remaining 
spermatogonia in vitA-deficient animals are arrested just before their differentiation into 
A1 spermatogonia. In rats and mice, reintroduction of vitA in the diet or systemic 
administration of different retinoids induces, within 24 hours, the Aal-A1 transition and, 
subsequently, the reinitiation of spermatogenesis in most of the tubules (van Pelt et 
al., 1995; Gaemers, van Pelt, van der Saag, & de Rooij, 1996; Schrans-Stassen, van 
de Kant, de Rooij, & van Pelt, 1999; and references therein). 
The presence of seminiferous tubule segments in which spermatogenesis is not 
restored several months after vitA replacement in vitA-deficient animals raises the 
question as to whether retinoid are also required for Aundiff spermatogonia self-renewal 
or survival, in addition to be instrumental to the Aal-A1 transition. A recent work using 
pulse labelling of spermatogonia subtypes in a vitA-deficient mouse model 
demonstrates that the GFRA1-positive spermatogonia, which comprises the actual 
stem cell pool, does not depend on ATRA signaling for self-renewal. ATRA is neither 
required for their differentiation into NGN3-positive Aundiff spermatogonia. However, 
NGN3-positive spermatogonia, a poised cell population that differentiates further into 
KIT-positive spermatogonia in homeostatic spermatogenesis, cannot do so and die in 
the absence of vitA (Ikami et al., 2015). Altogether, these data indicate that ATRA is 
indispensable in vivo to trigger the Aal-A1 transition and is independently required for 
the survival of some Aundiff spermatogonia. In contrast, stem spermatogonia can survive 
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and divide without ATRA. Whether ATRA is also required in differentiating 
spermatogonia has not been investigated so far.  
3.2. The sources of ATRA destined for spermatogenesis are intrinsic to the SE 
A major source of ATRA in the SE was identified using the Aldh1a1-3Ser−/− mutant 
mouse line as a model. In steady-state conditions, the most advanced GC ever present 
in Aldh1a1-3Ser−/− mutants are ZBTB16 positive, but STRA8 and KIT negative, Aundiff 
spermatogonia (Raverdeau et al., 2012). Interestingly, almost all these cells strongly 
express RARG indicating that they have the capacity to respond to ATRA. However, 
spermatogonia cannot cell-autonomously trigger the Aal-A1 transition because they do 
not possess the enzymatic machinery to make ATRA (Evans, Hogarth, Mitchell, & 
Griswold, 2014). Within twenty-four hours following an injection of ATRA, a majority of 
spermatogonia in Aldh1a1-3Ser−/− seminiferous tubules switch to a STRA8- and KIT-
positive phenotype. It is thus concluded that the only source of ATRA in the SE at the 
onset of the prepubertal period is RALDH activity in Sertoli cells and that it acts in a 
paracrine manner to instruct the initial Aal-A1 transition. 
Quite strikingly, spermatogenesis continues for months in Aldh1a1-3Ser−/− 
mutants after rescue by an injection of ATRA. This situation cannot be accounted for 
by a persistent effect of exogenous ATRA because its half-life is less than 1 hour in 
the mouse and direct measurements of ATRA levels in testes indicate that its residual 
amount 4 days following its injection is null (Hogarth et al., 2015a). Thus, once the first 
wave of spermatogenesis has progressed beyond a certain point, RALDH activity in 
Sertoli cells is no longer required for spermatogonia differentiation. (Raverdeau et al., 
2012). In this context, ATRA is necessarily produced either outside or within the SE 
but not in Sertoli cells. The interstitial spaces between seminiferous tubules contains 
two potential sources of ATRA for the SE: Leydig cells, which strongly and steadily 
express RALDH1, and capillaries that covey ATRA derived from the blood (Kane, 
Folias, Wang, & Napoli, 2008; Vernet et al., 2006a). ATRA from the interstitial tissue is 
however unable to trigger spermatogenesis in Aldh1a1-3Ser−/− mutants. This is likely 
due to the activity of peritubular myoid cells that surround the seminiferous tubules. 
Actually from birth to adulthood, these cells strongly express the CYP26A1 and 
CYP26B1 enzymes, whereas CYP26 are undetectable by ISH and IHC in the other 
cell populations of the post-natal testis (Vernet et al., 2006a; Wu, Wang, Guo, & Xu, 
2008). Interestingly, administration of the CYP26 inhibitor liarozole to Aldh1a1-3Ser−/− 
mutants can restore a complete spermatogenesis (Fig. 6). This experiment indicates 
that the catabolic barrier formed by the peritubular myoid cells is efficient in Aldh1a1-
3Ser−/− mutants and probably also functions in WT mice to degrade any ATRA present 
in the immediate environment of the seminiferous tubules, thus preventing inopportune 
occurrences of Aal-A1 transitions. Since ATRA present around the tubules is unable to 
reach spermatogonia in Aldh1a1-3Ser−/− mutants, the activity required to sustain their 
differentiation is necessarily supported by their progeny: RALDH2 in spermatocytes 
and spermatids is clearly the only possible source of ATRA for spermatogenesis in 
these mutants (Vernet et al., 2006a; Sugimoto, Nabeshima, & Yoshida, 2012), where 
it acts in a paracrine fashion to induce spermatogonia differentiation from the second 
round of spermatogonia differentiation onward. 
Ablation of Rdh10 in the SE also causes a block in spermatogenesis at the Aal-
A1 transition, which is rescued when RAL or ATRA are administered exogenously. 
Contrary to Aldh1a1-3Ser−/− mice, in which this block is definitive in the absence of 
retinoid treatment, spermatogenesis is spontaneously restored to normal in young in 
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the Rdh10-deficient adults at PNW9, suggesting that the first step in the synthesis of 
ATRA (transformation of vitA into RAL) is performed by an enzyme other than RDH10 
in adult testis (Tong, Yang, Davis, & Griswold, 2013). Interestingly, results similar to 
what is observed in Aldh1a1-3Ser−/− and Rdh10-deficient mutants are also seen 
following pharmacological inhibition of RALDH: when prepubertal mice were treated 
with WIN 18,446, the only GC type present within their seminiferous tubules is Aundiff 
spermatogonia (Hogarth et al., 2013). 
4. ATRA IS INSTRUMENTAL TO MEIOSIS IN SPERMATOCYTES 
It is commonly believed that since expression of Stra8 in GC is indispensable for 
their entry into meiosis, then expression of Stra8 also indicates their irreversible 
commitment towards meiosis (references in Mark, Teletin, Vernet, & Ghyselinck, 
2015). This may eventually apply to the situation in ovary where expression Stra8 by 
fetal gonocytes is temporally tightly correlated with the initiation of meiosis, as it 
precedes by only a few hours the expression of markers of meiotic prophase I. In 
contrast, in the developing and adult testis Stra8 expression in spermatogonia 
precedes their meiotic entry by about a week (Drumond, Meistrich, & Chiarini-Garcia, 
2011; Kluin, Kramer, & de Rooij, 1982; Mark, Teletin, Vernet, & Ghyselinck, 2015; Zhou 
et al., 2008). Additionally, synthesis of Stra8 mRNA and protein is biphasic in 
spermatogonia: both are detected in differentiating type A spermatogonia, but not in 
intermediate nor in type B spermatogonia, the latter representing the immediate 
precursors of preleptotene spermatocytes. Spermatocytes in S (preleptotene) phase 
reinitiate Stra8 expression before entering meiosis (Vernet et al., 2006b; Mark, Teletin, 
Vernet, & Ghyselinck, 2015; Fig. 5). 
In the male mouse, meiotic initiation occurs for the first time during prepuberty at 
about PND7, then meiosis recurs repeatedly and continuously throughout adult life 
(Drumond, Meistrich, & Chiarini-Garcia, 2011; Kluin, Kramer, & de Rooij, 1982). The 
involvement of ATRA in this process was investigated using Aldh1a1-3Ser−/− mutants in 
which spermatogenesis was rescued by an injection of ATRA to resume the Aal-A1 
transition (Raverdeau et al., 2012). Under these conditions, preleptotene 
spermatocytes expressing Stra8 and Rec8 (encoding a meiosis specific recombinase) 
appear, synchronously, 8 days post-ATRA injection in all seminiferous tubules. 
Treatment with the pan-RAR inverse agonist BMS-204493 prior to and during meiotic 
initiation in rescued Aldh1a1-3Ser−/− mutants abrogates Stra8 expression and induces 
cytological abnormalities which are identical to those displayed by Stra8-null 
spermatocytes. Actually, in the absence of STRA8 expression, leptotene 
spermatocytes undergo premature chromosome condensation yielding hyper 
condensed chromatin figures consisting in 40 univalent chromosomes which are thus 
similar to mitotic metaphases (Mark et al., 2008). The potential source of ATRA in 
Aldh1a1-3Ser−/− mutants at the time of meiotic initiation is represented by 
spermatocytes, which express RALDH2 (Vernet et al., 2006a; Raverdeau et al., 2012). 
Keeping in mind the possible artefactual effects of BMS-204493 mentioned above, 
these data may indicate a role for endogenous ATRA in the stable commitment to the 
meiotic cell cycle in the testis. A recent report further suggests that ATRA may also be 
required for meiotic recombination (Kent et al., 2016). 
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5. ATRA METABOLISM WITHIN THE SE CONTROLS THE TIMING 
AND SPATIAL PATTERNING OF SPERMATOGONIA 
DIFFERENTIATION 
At a given point along a murine seminiferous tubule, the transition from Aundiff to 
differentiating spermatogonia proceeds in a periodic manner, every 8.6 days, while 
their descendants are generated and displaced at a constant pace towards the lumen 
of the seminiferous tubules. These processes result in the formation of stratified, 
recurring, cellular associations of fixed composition between precise subtypes of 
spermatogonia, spermatocytes and spermatids, called stages of the SE cycle, each 
epithelial stage spanning a short segment along a tubule. Twelve stages (I to XII), are 
recognizable in the mouse SE, with stage I corresponding to the first step of spermatid 
maturation (reviewed in Russell, Ettlin, & Clegg, 1990; de Rooij, 1998; Fig. 7). The Aal-
A1 transition is the point of entry into the SE cycle, and four turns of this cycle are 
required for a GC to progress from a type A1 spermatogonium to a spermatozoon that 
is ready to be released in the tubule lumen. The SE cycle, as well as the repetitive 
patterning of GC associations along the seminiferous tubules, called wave of the SE, 
represent the keys for the physiologically asynchronous GC differentiation that allows 
a constant production of mature spermatids by the testis and a continuous release of 
spermatozoa in the epididymis. It is therefore paramount to the successful 
maintenance of fertility throughout the reproductive lifetime of males. 
5.1. The SE cycle and wave both rely on retinoid signaling 
The idea that retinoids could play a role in controlling the SE cycle came from 
observations made on vitA-deficient rats in which spermatogenesis was restored upon 
systemic administration of vitA and/or ATRA. Actually in retinoid-rescued rat testes, 
the full representation of the normal 14 stages of the SE is no longer seen. Instead, 
they contain only 3-4 stages, which are present at abnormally high frequencies, 
yielding an apparent “truncation” of the wave. Accordingly, the spermatogenesis of 
these animals is described as “synchronous”, referring to the near-identical timing of 
GC progression in the entire testis (Morales & Griswold, 1987; vanPelt & de Rooij, 
1990; Van Beek & Meistrich, 1990). More recently, it was shown that exposure of vitA-
sufficient prepubertal mouse testis to exogenous ATRA drives the entire Aundiff 
population to enter the differentiation pathway in the whole testis, resulting also in 
synchronous spermatogenesis at adulthood (Snyder, Davis, Zhou, Evanoff, & 
Griswold, 2011; Davis, Snyder, Hogarth, Small, & Griswold, 2013). 
VitA is also indispensable for the maintenance of the epithelial stages. This role 
was inferred from the study of Rbp4–/– mutant mice which are unable to mobilize their 
ROL liver stores because they lack the blood carrier Retinol-Binding Protein 
(Ghyselinck et al. 2006). In these mutants, the vitA-deficiency-induced defects 
progress over a period of several weeks, much earlier than in WT mice. Therefore, 
their timeline can be drawn, which allows investigating the target cells and 
physiological functions of retinoids in the SE. The seminiferous tubules of vitA-deficient 
Rbp4–/– mice display normal segments at any of the 12 stages of the cycle that co-exist 
with segments lacking one or two GC layers (e.g., entire spermatocyte or spermatid 
layers; Fig. 7). Importantly, these abnormal segments can all be classified as variants 
of the stages of the SE cycle, and aberrant cellular associations that would not fit in 
one of the canonical 12 stages are never found. Therefore, the tight coordination 
between spermatogonia differentiation and steps of meiosis and spermiogenesis is 
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maintained in conditions of decreased vitA availability. These observations lead to the 
conclusion that a major mechanism accounting for vitA-deficiency-induced failure of 
the SE cycle is the normal maturation of spermatocytes and spermatids in a situation 
where spermatogonia differentiation is temporarily arrested (Ghyselinck et al., 2006). 
5.2. Endogenous ATRA levels in the SE are tightly regulated 
Several observations support the notion that endogenous ATRA also regulates 
the SE cycle and wave. First, expression of the ATRA-target genes Stra8 in 
spermatocytes, and Stra6 in Sertoli cells peak at stages VII-VIII of the SE cycle (Vernet 
et al., 2006b). Second, ATRA is crucial for cellular processes which occur at stages 
VII-VIII of the cycle including Aal-A1 transition, entry of spermatocytes into meiosis and 
release of mature spermatids (spermiation) into the lumen of the seminiferous tubules 
(Raverdeau et al., 2012; Fig. 7). Third, measurement of ATRA levels in synchronized 
mouse testes support the view that an ATRA pulse occurs at stages VII-IX of the SE 
cycle (Hogarth et al., 2015a; Fig. 7). Altogether, these observations suggest that ATRA 
is only along distinct segments of the seminiferous tubules. 
The bioavailability of ATRA is controlled by regulation of the balance between its 
production and degradation. No variations in the levels of CYP26 enzymes exist across 
the SE cycle (Vernet et al., 2006a; Hogarth et al., 2015b). In contrast, several proteins 
involved in retinol storage and production of RAL represent potential candidates for 
contributing to how ATRA levels are regulated in a periodic manner along seminiferous 
tubules. The distribution pattern of Lrat transcripts in spermatids supports the 
possibility that retinoid storage is promoted during stages I-VI of the SE cycle (Vernet 
et al., 2006a). Rdh10 and dehydrogenase/reductase (SDR family) member 4 (Dhrs4) 
display SE stage-specific expressions, suggesting that conversion of vitA to RAL may 
occur only at specific sites along seminiferous tubules. However, the fact that 98% of 
the mutant mice lacking Rdh10 display a spermatogenesis with a normal frequency of 
the epithelial stages, indicates that RDH10 activity is not indispensable to regulate the 
wave of the SE cycle (Tong, Yang, Davis, & Griswold, 2013). 
5.3. RALDH activity regulates the spermatogenic wave 
The expression patterns of Aldh1a1 to Aldha3 genes has been extensively 
investigated: RALDH1 and RALDH2 are the main ATRA synthesizing enzymes in 
Sertoli cells and GC respectively, while RALDH3 is not detected in the SE (Vernet et 
al., 2006a, Bowles et al., 2009; Sugimoto, Nabeshima, & Yoshida, 2012; Kent et al., 
2016). In Sertoli cells of the adult testis, Aldh1a1 transcripts are expressed in a SE 
cycle-dependent manner with the highest levels being found at stages II-VII (Fig. 8). In 
GC, Aldh1a2 transcripts are expressed in a periodic manner with a peak in late 
pachytene and diplotene spermatocytes, at stages VIII to XII (Vernet et al., 2006a; 
Fig. 8). These periodic expressions likely reflect a functional role of RALDH. 
Interestingly, histological analyses show that the spatial distribution of the different SE 
stages is markedly altered in the testes of Aldh1a1–/– males: cross sections of the SE 
at the same stage are often assembled in defined territories that, according to anatomy, 
corresponds to a given seminiferous tubule (Nakata et al., 2015). This similarities 
strongly suggest that, the segment length occupied by a given stage is increased in 
Aldh1a1–/– mice. In contrast, the topography of the SE stages does not display any 
defined profile in WT testes (Fig. 8). This points to a hitherto ignored function of 
RALDH1 in regulating the wave of the SE cycle. 
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RALDH2 in spermatocytes and spermatids is sufficient to maintain a SE cycle in 
the complete absence of RALDH in Sertoli cells (Raverdeau et al., 2012). This 
observation suggests a role of ATRA synthesized by GC in regulating the SE cycle or 
wave. We have proposed that, in adult males, late pachytene spermatocytes present 
at stage VIII may control the tight coordination between the differentiation of Aal 
spermatogonia and entry into meiosis through cyclically modulating the ATRA 
environment of the cells (Raverdeau et al., 2012). To further establish the specific role 
of RALDH2 in the testicular ATRA biosynthesis, a GC specific ablation of Aldh1a2 is 
needed to circumvent the problem of embryonic lethality of the Aldh1a2 knockout mice. 
6. MALE GC ARE BOTH DIRECT AND REMOTE TARGETS OF 
ATRA ACTION: LESSONS FROM MOUSE MUTANTS LACKING 
RETINOID RECEPTORS 
6.1. RAR in fetal GC differentiation 
All 3 RAR isotypes are reported to be expressed in fetal testes and ovaries 
(Bowles et al., 2006). In mice lacking one RAR isotype, testis differentiation proceeds 
normally up to the start of puberty (Rara–/– and Rarg–/– mutants) or even beyond its 
completion (Rarb–/– mutants) in males, while females display a normal ovarian 
morphology and are fertile at adulthood. Compound mutants lacking 2 RAR isotypes 
die in utero or at birth and display multiple defects in many tissues, the spectrum of 
which varies between individuals (Mark, Ghyselinck, & Chambon, 2006). Their gonadal 
sex can be unambiguously diagnosed based on the arrangement of the somatic cells 
into compact cords, in male fetuses, as opposed to epithelial clusters with ill-defined 
borders, in female fetuses. Histological criteria are however far from being sufficient to 
assess the normality of the developing gonads. This is especially true for young Rar 
compound knockout fetuses, where variations in the timing of GC differentiation, 
already patent in the WT situation, seem to be exacerbated. It is nevertheless 
interesting to note that while reanalyzing the serial histological sections obtained more 
than 20 years ago from the three ED18.5 Rara–/–;Rarg–/– female fetuses ever produced 
so far (Mendelsohn et al., 1994), we discovered in preparing this review that one fetus 
completely lacked meiotic oocytes (Fig. 9). Demonstrating that this finding actually 
reflects GC autonomous effects of the absence of RAR awaits the generation of a 
genetic model in which signaling via all 3 RAR is abrogated specifically in GC, as a 
mean of eliminating any functional redundancy. 
6.2. RARG controls the capacity of spermatogonia to respond to ATRA 
Aundiff spermatogonia are present throughout the cycle of the SE, including stage 
VIII when the peak of ATRA concentration supposedly induces the Aal-A1 transition 
(Hogarth et al., 2015a; de Rooij & Russell, 2000). Therefore, a mechanism must exist 
that ensures the preservation of a stem cell pool while producing, at the same time, 
differentiating cells upon exposure to ATRA. Recent observations suggests that this 
mechanism relies on the differential expression of Rarg between subpopulations of 
undifferentiated spermatogonia: as opposed to their Aal progeny, As spermatogonia do 
not express Rarg and therefore maintain an undifferentiated state and self-renewal 
capabilities even in the of presence of high ATRA levels in the SE (Gely-Pernot et al., 
2012; Ikami et al., 2015). 
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The role of RARG in spermatogonia differentiation was initially inferred from the 
phenotypic analysis of Rarg knockout mice (Rarg–/– mutants). The seminiferous 
tubules of sexually mature, young (2-3 month-old), Rarg–/– mutants display segments 
lacking one or two GC layers around their entire circumference, thereby forming 
variants of the stages of the SE cycle, identical to those observed in vitA-deficient 
Rbp4–/– mice (Ghyselinck et al., 2006; Gely-Pernot et al., 2012). Since Rarg–/– 
spermatocytes and spermatids do not display features reminiscent of increased 
apoptosis or delayed differentiation, the presence of these variants most likely reflects 
the fact that the Aal-A1 transition is temporarily arrested. In some cases the Aal-A1 
transition appears to take place in due time, yielding normal stages, while in other 
instances no A1 spermatogonia are formed and Aal spermatogonia have to wait one (or 
several) SE cycles to transition to A1, yielding seminiferous tubule segments with 
missing generations of spermatocytes and spermatids. Because these variants also 
occur upon ablation of Rarg in spermatogonia only (RargSpg–/– mutants), it is concluded 
that RARG functions cell-autonomously in spermatogonia to control the Aal-A1 
transition. 
With respect to progression with ageing of testis defects, Rarg–/– mutants are 
similar, but not fully identical, to vitA-deficient mice. Actually, seminiferous tubules of 
1-year-old Rarg–/– mutants contain only Sertoli cells and spermatogonia, some of which 
still express markers of differentiation (e.g., KIT). Thus, in contrast to the vitA-deficient 
situation, inactivation of Rarg is not sufficient to arrest all spermatogonia at the Aal-A1 
transition. This discrepancy between the two situations is most readily accounted for 
by a functional redundancy between RARG and another RAR in spermatogonia, 
notably RARA which appears to be ubiquitously expressed at low levels not necessarily 
detected by IHC and ISH (Gely-Pernot et al., 2012). To get rid of any possible 
functional compensation, mice lacking all RAR in spermatogonia were generated 
(referred to as Rara;b;gSpg–/– mutants) (Gely-Pernot et al., 2015). In these mutants, 
ablation of Rar genes is efficient, as early as PND5, i.e., shortly after the onset of 
spermatogenesis during prepuberty. In young adults, the phenotypic outcome of 
ablating all RAR in spermatogonia is undistinguishable from that induced upon Rarg 
knockout, indicating that RARG is indeed the major functional RAR isotype in 
spermatogonia. In addition, the SE of 1 year-old Rara;b;gSpg–/– mutants contains only 
KIT-negative Aundiff spermatogonia (in addition to Sertoli cells), demonstrating that 
RARA or RARB in spermatogonia can compensate, at least in part, for the loss of 
RARG. 
6.3. The response of spermatogonia to ATRA relies on RXR/RAR heterodimers 
The ATRA signal is generally transduced by RXR/RAR heterodimers, notably 
during mouse embryonic development (Mark, Ghyselinck, & Chambon, 2006). 
However, it can also be relayed by RAR independently of RXR, as it is the case in 
Sertoli cells (Vernet et al., 2006b). To discriminate between these two possibilities in 
GC, mice lacking all RXR isotypes in spermatogonia, and hence also in their 
spermatocytes and spermatids descendants were generated (hereafter called 
Rxra;b;gSpg–/– mutants). Age-matched Rxra;b;gSpg–/– and Rara;b;gSpg–/– mutants display 
similar, if not identical, phenotypes indicating that RXR and RAR exert convergent 
functions in spermatogonia. As in addition, both anti-RXR and anti-RAR antibodies 
precipitate, with similar efficiencies, DNA sequences containing the RAR binding sites 
of the Stra8 promoter, it is concluded that RXR/RAR heterodimers are the functional 
units transducing the ATRA-signal in spermatogonia (Gely-Pernot et al., 2015). 
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To identify the ATRA-controlled genes in spermatogonia, organ cultures of 
Aldh1a1-3Ser−/− testes were treated with a RARG-selective agonist (BMS-189961) to 
initiate spermatogenesis. Microarray expression profiling identified Sall4, which 
encodes a zinc-finger transcription factor, amongst the few transcripts that are 
differentially expressed upon activation of RARG. Interestingly, mice deficient for Sall4 
in spermatogonia display testis defects that resemble those observed in Rxra;b;gSpg–/– 
and Rara;b;gSpg–/– mutants, namely lack of differentiating spermatogonia (Hobbs et al., 
2012). A RAR-binding region located in the first intron of Sall4 was identified. This 
region contains a RARE that binds to RXRA in combination with RARG, but not to 
RXRA nor to RARG alone, as revealed by electrophoretic mobility shift assays (Gely-
Pernot et al., 2015). It is thus proposed that ATRA-activated RXRA/RARG 
heterodimers increase the level of SALL4A protein in spermatogonia, thereby allowing 
the increase in Kit expression (Fig. 10) that is a hallmark of the Aal-A1 transition 
(Schrans-Stassen, van de Kant, de Rooij, & van Pelt, 1999). In agreement with this 
proposal, the amount of SALL4 protein detected in spermatogonia is higher at the A1 
stage than at the Aal stage (Hobbs et al., 2012). In addition to SALL4, a recent study 
shows that ATRA controls spermatogonia differentiation through activating replication-
dependent core histone genes (Chen et al., 2016). 
6.4. RARA in Sertoli cells also contribute to ATRA functions in the SE 
It is intriguing that spermatogonia differentiation is not stopped straight away in 
Rara;b;gSpg–/– and Rxra;b;gSpg–/– mutants, but instead proceeds during several weeks 
in young adults (Gely-Pernot et al., 2015). This observation suggests the existence of 
a subpopulation of Aal spermatogonia that are committed to become A1 even though 
they are unable to cell-autonomously respond to ATRA. Given the pivotal role of ATRA 
in spermatogonia differentiation, instructing the Aal-A1 transition in this subpopulation 
may nevertheless require an ATRA signal mediated by the Sertoli cell, which 
expresses RARA and is the only somatic cell-type present in the SE. We propose that 
Sertoli cell responds to ATRA by synthesizing and secreting yet unknown paracrine 
signal(s) that stimulate a subpopulation of Aal spermatogonia to transition to A1 with no 
need for functional RXR/RAR heterodimers within these spermatogonia. This proposal 
is supported by the observation that the only GC ever present in the SE of mice lacking 
both RARA in Sertoli cells and RARG in spermatogonia (i.e., RaraSer–/–;Rarg–/– 
mutants) are undifferentiated spermatogonia, as it is the case when ATRA synthesis 
abolished in the SE (Gely-Pernot et al., 2015). 
It is also interesting to note that, in addition to differentiating spermatogonia, 
spermatocytes are also generated in testes of Rara;b;gSpg–/– and Rxra;b;gSpg–/– mutants. 
Moreover, meiosis proceeds at a normal pace, despite the absence of either RAR or 
RXR in all spermatocytes. Therefore, if ATRA is actually a mandatory MIS, then it 
operates in Sertoli cells rather than in GC (Gely-Pernot et al., 2015). 
7. CONCLUDING REMARKS 
An active ATRA signaling pathway is instrumental to the onset of oogenesis as 
well as to the initiation and maintenance of spermatogenesis in the mouse. 
Interestingly, it is also critically required in this species to disengage spermatozoa from 
the Sertoli cell cytoplasm during spermiation (Mark, Teletin, Vernet, & Ghyselinck, 
2015; and references therein; Fig. 7) and to promote the expulsion of the secondary 
oocyte from the mature follicle at ovulation (Kawai, Yanaka, Richards, & Shimada, 
2016; Fig. 1). Gametogenesis is similar in mice and humans, notably with respect to 
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the subtypes of GC, the sequence of cellular events involved in the differentiation 
cascade and the expression of regulatory molecules (Wu et al., 2009). In humans, a 
direct effect of ATRA on meiosis has been shown only in the ovary (Le Bouffant et al., 
2010). Nonetheless, the demonstration that the bis-(dichloroacetyl)-diamine WIN 
18,446 exerts its deleterious effects on human sperm counts and SE histology through 
its property to inhibit RALDH activity supports the view that ATRA is also required for 
human spermatogenesis (Hogarth et al., 2013). 
In this context it is worth noting that disturbances of the vitA metabolism caused 
by exposure to omnipresent environmental pollutants such as dioxin-like compounds 
or phthalates are strongly suspected to participate in the decrease of male fertility 
observed in industrialized countries (Novák, Benísek, & Hilscherová, 2008; Sarath 
Josh et al., 2014). Moreover, possible side effects on human fertility of pharmacological 
doses of retinoids used in the treatment of acne have not been evaluated so far. In this 
context, it is crucial to decipher the molecular mechanisms by which ATRA controls 
gametogenesis. 
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Figures 
 
Figure 1. Key stages of fetal and postnatal germ cell development. Fetal period: 
female gonocytes enter meiosis prior to birth, while male gonocytes undergo a mitotic 
cell cycle arrest. Prepuberty: during the first postnatal week, male gonocytes resume 
proliferation and migrate from the center of the seminiferous cords to the basement 
membrane, where they generate spermatogonia. Oogenesis and spermatogenesis are 
completed at puberty. Meiotic cells (oocytes or spermatocytes) and male post-meiotic 
cells (spermatids) are in orange and green, respectively. Supporting somatic cells 
(follicular or Sertoli cells) are represented in grey. Legend: C and T, seminiferous cords 
and tubules, respectively; F, ovarian follicles. Processes requiring ATRA are drawn on 
a yellow background. See the main text for details. 
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Figure 2. Regulation of retinoid signaling. Vitamin A (vitA) is provided to cells either 
by the blood, where it circulates bound to the vitA-binding protein (RBP). In cells, vitA 
is locally stored in the form of vitA esters generated through the transesterification 
activity of LRAT (lecithin retinol acyltransferase, the most potent vitA-esterifying 
enzyme). VitA is liberated from vitA-ester stores through the hydrolyzing activity of 
retinyl ester hydrolases (REH). In ATRA synthesizing cells, vitA is oxidized into 
retinaldehyde (RAL) by alcohol dehydrogenases (ADH) and short chain retinol 
dehydrogenases (RDH). RAL dehydrogenases (RALDH1, 2 and/or 3) then generate 
ATRA, which binds within the nucleus to a RAR forming a heterodimer complex with a 
RXR. RAR/RXR modulate transcription by binding to DNA at RARE motifs located in 
regulatory regions of ATRA target-genes. In cells expressing CYP26A1, B1 and/or C1 
enzymes, ATRA is hydroxylated into polar compounds such as 4-oxo- and 4-hydroxy-
retinoic acid (4-oxo-RA and 4-OH-RA, respectively), which are subject to further 
metabolism and elimination. ATRA often acts in a paracrine manner on neighboring 
cells, but there also is evidence for autocrine effects in cells that synthesize it. Dashed 
line indicate diffusion of retinoids through cell membranes. See the main text for details.  
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Figure 3. Distribution patterns of ATRA synthesizing and degrading enzymes in 
the vicinity of gonocytes, around the time of their meiotic entry in the female. (A-
L) Transverse histological sections of ED12.5, ED13.5 and ED14.5 fetuses 
immunolabelled with antibodies to RALDH1 or RALDH2 (from Abcam; red signals) and 
to TRA98 (from Abcam), a nuclear protein specifically expressed in (some) gonocytes 
(green signals). The sections were counterstained with 4′,6-diamidino-2-phenylindole 
(DAPI; blue signal) to label cell nuclei. RALDH1 and RALDH2, are restricted to the 
somatic cells located in the gonad (ovary, Ov; testis, Te), the coelomic epithelium (Ce) 
and the mesonephros (Me). Gonocytes, either positive or negative for TRA98, never 
express any of the two RALDH. (M-P) Adjacent (M, N) or consecutive (O, P) sections 
hybridized with anti-sense probes to Aldh1a1 and Cyp26b1 as described (Vernet et al., 
2006a). Note that some of the immature Sertoli cells within the nascent testis cords 
express both transcripts. The ISH signals were converted to a red color and the 
histological sections were counterstained with DAPI. K, (definitive) kidney; M, Müllerian 
duct; W, Wolffian duct. Bar in P: 160 µm (A-P).  
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Figure 4. The transition from gonocytes to differentiating spermatogonia, but not 
the formation of undifferentiated spermatogonia, is impaired in the absence of 
ATRA in the seminiferous epithelium. (A, B) In both Aldh1a1-3Ser-/- and WT mice at 
ED18.5, the proliferation marker MKI67 (red signal, A) is strictly confined to the somatic 
cells, including immature Sertoli cells at the periphery of the seminiferous cords (dotted 
white line), while expression of KIT (B, red signal) is identical in GC. (C-E) Between 
ED18.5 and PND3, expression of GFRA1 (C, green signal) and ZBTB16 (D and E, 
green and yellow signals) also is identical in GC of both Aldh1a1-3Ser-/- and WT mice. 
(F) Percentage of cross-sections of seminiferous cords harboring GC expressing: 
ZBTB16 (green lines), KIT (pink lines) and STRA8 (purple lines) in WT (solid lines) and 
Aldh1a1-3Ser-/- (dotted lines) mice, at the indicated ages. The bars represent mean ± 
SEM (n= 3 mice, > 200 cross sections per mice). (G-J) STRA8 and KIT (red signals) 
are not expressed in spermatogonia from Aldh1a1-3Ser-/- testes (H, J), in contrast to the 
WT situation (G, I). Scale bars: 30 µm (A-C, H, I) and 160 µm (D-G).  
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Figure 5. Spermatogonia differentiation assessed by immunohistochemistry. 
Because identification of spermatogonia subtypes at the morphological level can only 
rely on differences in nuclear shape and heterochromatin appearance that are both 
subtle and variable, immunohistochemical assays represent a valuable alternative. 
GFRA1 (light green line) is strongly expressed at the surface of Asingle (As) and Apaired 
(Apr), and faintly in Aaligned-4 (Aal-4) spermatogonia (Gely-Pernot et al., 2012). ZBTB16, 
a nuclear protein (dark green line), is frequently considered as a marker Aundiff 
spermatogonia, as it is required for the maintenance of the spermatogonia stem cell 
pool (Buaas et al., 2004; Costoya et al., 2004). However, it is actually also strongly 
expressed in A1-A4 spermatogonia and, albeit at low levels, also in intermediary (int) 
and B spermatogonia (our personal observations). (iii) STRA8 (purple line), is 
expressed in A1-A4 spermatogonia, absent in Int and B spermatogonia and re-
expressed in preleptotene (prL) and leptotene (L) spermatocytes (Mark, Teletin, 
Vernet, & Ghyselinck, 2015). Expression of the tyrosine kinase receptor KIT (pink line) 
is essential to the Aal-A1 transition (Schrans-Stassen et al., 1999; Kissel et al, 2000; 
Blume-Jensen et al., 2000) and is restricted to differentiating (A1 to B) spermatogonia 
and prL spermatocytes (our observations). Note that: (i) the topological arrangement 
of As, Apr, and Aal spermatogonia can only be visualized in whole mounts of 
seminiferous tubules; (ii) there are currently no marker that allow A1-A4 spermatogonia 
to be distinguished from one-another without knowing the stage of the SE cycle within 
which they reside. Cellular event requiring ATRA are on a yellow background. 
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Figure 6. Pharmacological inhibition of CYP26 enzymes triggers 
spermatogenesis in a seminiferous epithelium that lacks all ATRA synthetic 
activities. Aldh1a1-3Ser–/– males received intra-peritoneal injections of of vehicle (a 
mixture of sunflower oil and ethanol) or liarozole (40 mg/kg) for 3 consecutive days at 
PNW3 and were sacrificed at PNW6. Testis section were stained with hematoxylin 
eosin. (A) After administration of the vehicle only, spermatogenesis remains blocked 
at the spermatogonia stage. (B) After treatment by liarozole, spermatogenesis 
progresses synchronously throughout the testis, to round spermatids. Legend: prL and 
P, preleptotene and pachytene spermatocytes, respectively; L, Leydig cells; R, round 
spermatids; SG, spermatogonia. Arrowheads point to nuclei of peritubular myoid cells. 
Bar in B: 80 µm (A and B). 
 
Figure 7. Diagram depicting the organization of the murine SE and the cellular 
associations (stages of the SE) present at the time of the ATRA pulse (in yellow). 
GC are organized in a stratified fashion from the periphery to the lumen of the 
seminiferous epithelium, forming three to four distinct layers. The most peripheral 
layer, in contact with the basement membrane, contains spermatogonia (white, Aal; 
blue, A1; pink, B) and preleptotene spermatocytes (light orange), while more advanced 
spermatocytes (dark orange) are progressively displaced in the intermediate layer and 
post-meiotic cells (green, round, and blue, elongating, spermatids) reside in the layers 
closest to the lumen of the tubules. Roman numerals designate the 12 stages of the 
SE cycle. Cellular processes promoted by the rise in ATRA concentrations in the SE 
are indicated by the red arrows. For further details see the main text. 
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Figure 8. Roles for ATRA-synthesizing enzymes in regulating the SE cycle and 
wave. (A) In situ hybridization (ISH) using an anti-sense probe to Aldh1a1: higher 
mRNA levels (purple signals) are detected in Sertoli cells at stages II-VII of the SE 
cycle, as compared to stages VIII-XII and I. (B) ISH using an anti-sense probe to 
Aldh1a2: high mRNA levels are detected in spermatocytes at the late pachytene and 
diplotene stages (present at epithelial stages VIII to XII), as compared to 
spermatocytes present at stages I-VI; a weak ISH signal is also detected in round 
spermatids at stages II-VI. In the lower panels of (A) and (B), the ISH signals were 
converted to a red color, the histological sections were counterstained with 4′,6-
diamidino-2-phenylindole (blue signal) to label nuclei, and with Alexa Fluor 488-
conjugated peanut agglutinin (green signal) to label acrosomal systems. Epithelial 
stages were defined according to Russell, Ettlin, & Clegg (1990), taking into 
consideration the shape of acrosomes (green signal). Roman numerals designate 
stages of the seminiferous epithelium cycle. Abbreviations: L, Leydig cells; R, round 
spermatids; S, spermatocytes. (C, D) transverse histological sections though testes of 
(C) WT and (D) Aldh1a1–/– mutants (see the main text for further details). Each colored 
spot represents a cross-section of a seminiferous tubule. Stages of the SE or group of 
stages are indicated in different colors: black, stages I-III; red, stage IV; green, stages 
V and VI; dark blue, stages VII and VIIII; light blue, stage IX; pink, stage X; orange 
stage XI; yellow, stage XII.  
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Figure 9. Meiotic oocytes are lacking in the ovary of some mouse mutant fetuses 
lacking both RARA and RARG. Representative histological sections of ovaries from 
ED18.5 WT and Rara–/–;Rarg–/– female mice. See the main text for further details. Black 
and yellow arrows point to oocytes and ovarian somatic cells respectively. Trichrome 
stain. Bar in B = 30 µm (A and B). 
 
Figure 10. A model for the regulation of Kit expression by ATRA during the 
transition from Aal to A1 spermatogonia. Upper panel: In Aal spermatogonia, ATRA 
is not available to activate the RXRA/RARG heterodimer and thus Sall4 is transcribed 
at low levels. Transcription of Kit is also low because ZBTB16 is bound to its promoter 
(Filipponi et al, 2007). Lower panel: at the Aal-A1 transition, ATRA activates the 
RXRA/RARG heterodimer, which increases Sall4 expression. SALL4 in large amount 
can then sequesters ZBTB16, clearing thereby the Kit promoter and relieving the 
repression normally exerted by ZBTB16 (Hobbs et al., 2012). ATRA is also proposed 
to increase the level of SOHLH1, which can replace ZBTB16 on regulatory regions to 
increase Kit expression (Barrios et al., 2012). 
